Allergan cutting jobs ahead of Restasis competition

By Jaime De Leon | Jan 5, 2018 | 9:12 PM GMT

Allergan plc (NYSE:AGN) announced details Thursday of a plan to reduce costs as it braces for potential generic

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE